Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global, phase 3 randomised controlled trial
Incyte Corporation
Sheela Rao; Emmanuelle Samalin-Scalzi; Ludovic Evesque; Meher Ben Abdelghani; Federica Morano; Amitesh Roy; Laetitia Dahan; Stefano Tamberi; Amandeep Singh Dhadda; Mark P Saunders; Nathalie Casanova; Rosine Guimbaud; Astrid Lievre; Joan Maurel; Marwan Fakih; Chuan Tian; Jill Harrison; Mark M Jones; Mark Cornfeld; Jean-Philippe Spano; Pauline Rochefort; POD1UM-303/InterAACT-2 study investigators